Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Periodic Fever Syndrome Market: By Treatment: Oral Anti-Inflammatory Drugs, Non-Steroidal Anti-Inflammatory Drugs, Others; By Indication; By Route of Administration; By Distribution Channel; By End Use; Regional Analysis; Historical Market and Forecast (2015-2025); Competitive Landscape; Industry Events and Developments

Global Periodic Fever Syndrome Market Outlook

The global periodic fever syndrome market is expected to witness a steady growth in the forecast period of 2020-2025.

 

North America to Significantly Contribute to the Periodic Fever Syndrome Industry Growth

North America is one of the leading regions in the global periodic fever syndrome industry. The region accounts for a significant share of the total market value owing to the growing penetration of the major players in the region and the greater focus on patient care and monitoring. The growing investments in the research and development activities, coupled with the availability of advanced healthcare infrastructure in the region, are aiding the industry growth in North America. However, there still remains the difficulty in the diagnosis of periodic fever syndrome due to unrelated symptoms, which is a key challenge faced by the market players.

 

Periodic Fever Syndrome: Industry Definition and Segmentation

Periodic fever syndromes are a group of rare autoinflammatory diseases in which a patient experiences recurrent episodes of fever over time, usually accompanied by similar symptoms. The disease causes periodic (episodic) fever, often accompanied by rashes and joint pain, that do not have an infectious (virus, bacteria) cause, and each episode of fever usually lasts roughly the same length of time. These disorders are genetic conditions and are very rare. Among children, periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is the most common type of periodic fever syndrome. These disorders are milder and less obvious in adults than in children.

On the basis of treatment, the market is divided into:

  • Oral Anti-Inflammatory Drugs
  • Non-Steroidal Anti-Inflammatory Drugs
  • Anti-TNF Therapy
  • Statins
  • Others

By indication, the industry can be segmented into:

  • Hyperimmunoglobulinemia D Syndrome 
  • Familial Mediterranean Fever 
  • TNF Receptor-Associated Periodic Syndrome 
  • Cryopyrin-Associated Periodic Syndrome
  • Others

The various routes of administration are:

  • Oral
  • Injections
  • Others

The major distribution channels in the industry include:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online
  • Others

Based on end use sector, the industry can be categorised into:

  • Hospitals
  • Speciality Centres
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising Health Awareness and New Drug Approvals by the Government Bodies to Augment the Global Market for Periodic Fever Syndrome

There is limited knowledge and limited treatment options available for periodic fever syndrome. The growing government initiatives to raise public awareness regarding such rare disorders are aiding the industry growth. Currently, the treatment of periodic fever syndrome is carried out using oral anti-inflammatory drugs, such as corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs), among others, which helps to control the symptoms associated with the disease but does not assist in its elimination. However, the rapid technological advancements and the growing research activities are leading to the development of improved diagnostic facilities and new drugs and therapies. The new drug approvals for the treatment of this rare disorder is expected to have a positive effect on the expansion of the periodic fever syndrome industry. In developed nations, the growing government investments in the development of healthcare infrastructure will further boost the market expansion over the forecast period.

 

Key Industry Players in the Global Periodic Fever Syndrome Market

The report gives a detailed analysis of the following key players in the global periodic fever syndrome market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Swedish Orphan Biovitrum AB
  • Novartis AG
  • Texas Allergy Group, PLLC
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and End Uses
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Periodic Fever Syndrome Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Periodic Fever Syndrome Historical Market (2015-2019) 
    8.3    Global Periodic Fever Syndrome Market Forecast (2020-2025)
    8.4    Global Periodic Fever Syndrome Market by Treatment
        8.4.1    Oral Anti-Inflammatory Drugs
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2015-2019)
            8.4.1.3    Forecast Trend (2020-2025)
        8.4.2    Non-Steroidal Anti-Inflammatory Drugs
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2015-2019)
            8.4.2.3    Forecast Trend (2020-2025)
        8.4.3    Anti-TNF Therapy
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2015-2019)
            8.4.3.3    Forecast Trend (2020-2025)
        8.4.4    Statins
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2015-2019)
            8.4.4.3    Forecast Trend (2020-2025)
        8.4.5    Others
    8.5    Global Periodic Fever Syndrome Market by Indication
        8.5.1    Hyperimmunoglobulinemia D Syndrome
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2015-2019)
            8.5.1.3    Forecast Trend (2020-2025)
        8.5.2    Familial Mediterranean Fever
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2015-2019)
            8.5.2.3    Forecast Trend (2020-2025)
        8.5.3    TNF Receptor-Associated Periodic Syndrome
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2015-2019)
            8.5.3.3    Forecast Trend (2020-2025)
        8.5.4    Cryopyrin-Associated Periodic Syndrome
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2015-2019)
            8.5.4.3    Forecast Trend (2020-2025)
        8.5.5    Others
    8.6    Global Periodic Fever Syndrome Market by Route of Administration
        8.6.1    Oral
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2015-2019)
            8.6.1.3    Forecast Trend (2020-2025)
        8.6.2    Injections
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2015-2019)
            8.6.2.3    Forecast Trend (2020-2025)
        8.6.3    Others
    8.7    Global Periodic Fever Syndrome Market by Distribution Channel
        8.7.1    Hospital Pharmacy
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2015-2019)
            8.7.1.3    Forecast Trend (2020-2025)
        8.7.2    Retail Pharmacy
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2015-2019)
            8.7.2.3    Forecast Trend (2020-2025)
        8.7.3    Online
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2015-2019)
            8.7.3.3    Forecast Trend (2020-2025)
        8.7.4    Others
    8.8    Global Periodic Fever Syndrome Market by End Use
        8.8.1    Hospitals
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2015-2019)
            8.8.1.3    Forecast Trend (2020-2025)
        8.8.2    Speciality Centres
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2015-2019)
            8.8.2.3    Forecast Trend (2020-2025)
        8.8.3    Others
    8.9    Global Periodic Fever Syndrome Market by Region
        8.9.1    Market Share
            8.9.1.1    North America
            8.9.1.2    Europe
            8.9.1.3    Asia Pacific
            8.9.1.4    Latin America
            8.9.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2015-2019)
        9.1.2    Forecast Trend (2020-2025)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2015-2019)
        9.2.2    Forecast Trend (2020-2025)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2015-2019)
        9.3.2    Forecast Trend (2020-2025)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2015-2019)
        9.4.2    Forecast Trend (2020-2025)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2015-2019)
        9.5.2    Forecast Trend (2020-2025)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Swedish Orphan Biovitrum AB
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Novartis AG
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Texas Allergy Group, PLLC
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Periodic Fever Syndrome Market: Key Industry Highlights, 2015 and 2025
2.    Global Periodic Fever Syndrome Historical Market: Breakup by Treatment (USD Billion), 2015-2019
3.    Global Periodic Fever Syndrome Market Forecast: Breakup by Treatment (USD Billion), 2020-2025
4.    Global Periodic Fever Syndrome Historical Market: Breakup by Indication (USD Billion), 2015-2019
5.    Global Periodic Fever Syndrome Market Forecast: Breakup by Indication (USD Billion), 2020-2025
6.    Global Periodic Fever Syndrome Historical Market: Breakup by Route of Administration (USD Billion), 2015-2019
7.    Global Periodic Fever Syndrome Market Forecast: Breakup by Route of Administration (USD Billion), 2020-2025
8.    Global Periodic Fever Syndrome Historical Market: Breakup by Distribution Channel (USD Billion), 2015-2019
9.    Global Periodic Fever Syndrome Market Forecast: Breakup by Distribution Channel (USD Billion), 2020-2025
10.    Global Periodic Fever Syndrome Historical Market: Breakup by End Use (USD Billion), 2015-2019
11.    Global Periodic Fever Syndrome Market Forecast: Breakup by End Use (USD Billion), 2020-2025
12.    Global Periodic Fever Syndrome Historical Market: Breakup by Region (USD Billion), 2015-2019
13.    Global Periodic Fever Syndrome Market Forecast: Breakup by Region (USD Billion), 2020-2025
14.    North America Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
15.    North America Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
16.    Europe Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
17.    Europe Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
18.    Asia Pacific Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
19.    Asia Pacific Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
20.    Latin America Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
21.    Latin America Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
22.    Middle East and Africa Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
23.    Middle East and Africa Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
24.    Global Periodic Fever Syndrome Market Structure

Key Questions Answered in the Report

The global periodic fever syndrome market is estimated to witness a steady growth in the forecast period of 2020-2025.

The major drivers of the industry, such as rising disposable incomes, increasing population, rising focus on patient care and monitoring, increasing government initiatives to raise public awareness regarding such rare disorders, growing technological advancements, rising research activities, and new drug approvals for the treatment, are expected to aid the market growth.

The key trends guiding the growth of the market include the rising investments in the research and development activities and the increasing availability of advanced healthcare infrastructure.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading treatments of periodic fever syndrome in the market are oral anti-inflammatory drugs, non-steroidal anti-inflammatory drugs, anti-TNF therapy, and statins, among others.

The major indications of periodic fever syndrome in the industry are hyperimmunoglobulinemia D syndrome, familial mediterranean fever, TNF receptor-associated periodic syndrome, and cryopyrin-associated periodic syndrome, among others.

The significant routes of administration in the market are oral and injections, among others.

The major distribution channels in the industry are hospital pharmacy, retail pharmacy, and online, among others.

The leading end-use sectors in the market are hospitals and speciality centres, among others.

The major players in the industry are Swedish Orphan Biovitrum AB, Novartis AG, and Texas Allergy Group, PLLC, among others.

Analyst Review

The global periodic fever syndrome market is being driven by the rising advancements in the healthcare sector. Aided by the rising R&D activities, the market is expected to witness a steady growth in the forecast period of 2020-2025.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on treatment, the market is segmented into oral anti-inflammatory drugs, non-steroidal anti-inflammatory drugs, anti-TNF therapy, and statins, among others. On the basis of indication, the market is divided into hyperimmunoglobulinemia D syndrome, familial mediterranean fever, TNF receptor-associated periodic syndrome, and cryopyrin-associated periodic syndrome, among others. By route of administration, the industry is segmented into oral and injections, among others. The leading distribution channels in the market are hospital pharmacy, retail pharmacy, and online, among others. Based on end use, the industry is divided into hospitals and speciality centres, among others. The major regional markets for periodic fever syndrome are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Swedish Orphan Biovitrum AB, Novartis AG, and Texas Allergy Group, PLLC, among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1099     $999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$ 2999     $1999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$ 3999     $2999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$ 4999     $3999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Global ECG Device Market Report and Forecast 2020-2025


Global Proctoscope Market Report and Forecast 2020-2025


Global Pulse Lavage Market Report and Forecast 2020-2025


Global Skin Tears Treatment Market Report and Forecast 2020-2025



NEWSLETTER